References
- Wong T, Yap T, Wiesenfeld D. Common causes of’swelling’in the oral cavity. Australian Journal of General Practice. 2020;49(9):575-80.
- Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mendenhall NP. Ameloblastoma. American journal of clinical oncology. 2007;30(6):645-8.
- Ajila V, Hegde S. Ameloblastomas vs recurrent ameloblastomas: A systematic review. Journal of Oral Medicine and Oral Surgery. 2022;28(1):11.
- Brown NA, Betz BL. Ameloblastoma: a review of recent molecular pathogenetic discoveries. Biomarkers in cancer. 2015;7:BIC. S29329.
- Bassey G, Osunde O, Anyanechi C. Maxillofacial tumors and tumor-like lesions in a Nigerian teaching hospital: an eleven year retrospective analysis. African health sciences. 2014;14(1):56-63.
- Oomens MA, Van der Waal I. Epidemiology of ameloblastomas of the jaws; a report from the Netherlands. Medicina oral, patologia oral y cirugia bucal. 2014;19(6):e581.
- Bansal S, Desai R, Shirsat P, Prasad P, Karjodkar F, Andrade N. The occurrence and pattern of ameloblastoma in children and adolescents: an Indian institutional study of 41 years and review of the literature. International journal of oral and maxillofacial surgery. 2015;44(6):725-31.
- Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Archiv. 2018;472:331-9.
- Effiom O, Ogundana O, Akinshipo A, Akintoye S. Ameloblastoma: current etiopathological concepts and management. Oral diseases. 2018;24(3):307-16.
- Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, et al. Global incidence and profile of ameloblastoma: A systematic review and meta‐analysis. Oral diseases. 2020;26(1):12-21.
- Anpalagan A, Tzortzis A, Twigg J, Wotherspoon R, Chengot P, Kanatas A. Current practice in the management of peripheral ameloblastoma: a structured review. British Journal of Oral and Maxillofacial Surgery. 2021;59(1):e1-e8.
- Hsu M-H, Chiang M-L, Chen J-K. Unicystic ameloblastoma. Journal of Dental Sciences. 2014;9(4):407-11.
- Barrett AW, Sneddon KJ, Tighe JV, Gulati A, Newman L, Collyer J, et al. Dentigerous cyst and ameloblastoma of the jaws: Correlating the histopathological and clinicoradiological features avoids a diagnostic pitfall. International Journal of Surgical Pathology. 2017;25(2):141-7.
- Li T-J, Wu Y-T, Yu S-F, Yu G-Y. Unicystic ameloblastoma: a clinicopathologic study of 33 Chinese patients. The American journal of surgical pathology. 2000;24(10):1385-92.
- Huang I-Y, Lai S-T, Chen C-H, Chen C-M, Wu C-W, Shen YH. Surgical management of ameloblastoma in children. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2007;104(4):478-85.
- Sahoo S, Alatassi H, Bernstein M, Slone S, Chagpar A. Breast carcinoma metastatic to ameloblastoma: a unique tumour‐to ‐tumour metastasis. Histopathology. 2007;50(6):815-7.
- Pinheiro J, Freitas V, Moretti A, Jorge A, Jaeger RG. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology. 2004;45(1):65-72.
- Barnes L. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. 2005;232.
- Sherlin HJ, Natesan A, Ram P, Ramani P, Thiruvenkadam C. Immunohistochemical profiling of ameloblastomas using cytokeratin, vimentin, smooth muscle actin, CD34 and S100. Annals of maxillofacial surgery. 2013;3(1):51-7.
- Jussila M, Thesleff I. Signaling networks regulating tooth organogenesis and regeneration, and the specification of dental mesenchymal and epithelial cell lineages. Cold Spring Harbor perspectives in biology. 2012;4(4):a008425.
- Fan K, Andrews BT, Tabit CJ, Bradley JP. The Sarnat studies in craniofacial biology. Journal of Craniofacial Surgery. 2012;23(1):37-43.
- Heikinheimo K, Jee KJ, Niini T, Aalto Y, Happonen R-P, Leivo I, et al. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. Journal of dental research. 2002;81(8):525-30.
- Siar CH, Nagatsuka H, Han PP, Buery RR, Tsujigiwa H, Nakano K, et al. Differential expression of canonical and non‐canonical Wnt ligands in ameloblastoma. Journal of oral pathology & medicine. 2012;41(4):332-9.
- Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, et al. Activating FGFR2–RAS–BRAF mutations in ameloblastoma. Clinical Cancer Research. 2014;20(21):5517-26.
- Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski J, et al. High frequency of BRAF V600E mutations in ameloblastoma. The Journal of pathology. 2014;232(5):492-8.
- Brown NA, Betz BL, Weigelin HC, Elenitoba-Johnson KS, Lim MS, Bailey NG. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia. American journal of clinical pathology. 2015;143(1):89-99.
- Mishra P, Panda A, Bandyopadhyay A, Kumar H, Mohiddin G. Sonic hedgehog signalling pathway and ameloblastoma–a review. Journal of clinical and diagnostic research: JCDR. 2015;9(11):ZE10.
- Nair PR. Pathogenesis of apical periodontitis and the causes of endodontic failures. Critical Reviews in Oral Biology & Medicine. 2004;15(6):348-81.
- Wright JM, Vered M. Update from the 4th edition of the World Health Organization classification of head and neck tumours: odontogenic and maxillofacial bone tumors. Head and neck pathology. 2017;11(1):68-77.
- Kumamoto H, Yamauchi K, Yoshida M, Ooya K. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. Journal of oral pathology & medicine. 2003;32(2):114-20.
- Hendarmin L, Sandra F, Nakao Y, Ohishi M, Nakamura N. TNFα played a role in induction of Akt and MAPK signals in ameloblastoma. Oral oncology. 2005;41(4):375-82.
- Fuchigami T, Ono Y, Kishida S, Nakamura N. Molecular biological findings of ameloblastoma. Japanese Dental Science Review. 2021;57:27-32.
- Liu X, Chen Z, Lan T, Liang P, Tao Q. Upregulation of interleukin-8 and activin A induces osteoclastogenesis in ameloblastoma. International journal of molecular medicine. 2019;43(6):2329-40.
- Siqueira AS, Carvalho MR, Monteiro AC, Freitas VM, Jaeger RG, Pinheiro JJ. Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour. Histopathology. 2010;57(1):128-37.
- Ribeiro BF, Iglesias DPP, Nascimento G, Galvão HC, Medeiros AMCd, Freitas RdA. Immunoexpression of MMPs‐1, ‐2, and ‐9 in ameloblastoma and odontogenic adenomatoid tumor. Oral diseases. 2009;15(7):472-7.
- Luo H-Y, Yu S-F, Li T-J. Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas. International journal of oral and maxillofacial surgery. 2006;35(8):750-5.
- Andisheh-Tadbir A, Fakharian M. HSP70 expression in dentigerous cyst, odontogenic keratocyst, and ameloblastoma. Oral and maxillofacial surgery. 2015;19(3):287-91.
- Salehinejad J, Zare-Mahmoodabadi R, Saghafi S, Jafarian AH, Ghazi N, Rajaei A-R, et al. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor. Journal of oral science. 2011;53(2):213-7.
- Sathi G, Nagatsuka H, Tamamura R, Fujii M, Gunduz M, Inoue M, et al. Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma. Histopathology. 2008;53(4):458-67.
- Sandra F, Hendarmin L, Kukita T, Nakao Y, Nakamura N, Nakamura S. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral oncology. 2005;41(6):637-44.
- Kumamoto H, Ooya K. Expression of parathyroid hormone‐related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor‐κB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas. Journal of oral pathology & medicine. 2004;33(1):46-52.
- Fuchigami T, Kibe T, Koyama H, Kishida S, Iijima M, Nishizawa Y, et al. Regulation of IL-6 and IL-8 production by reciprocal cell-to-cell interactions between tumor cells and stromal fibroblasts through IL-1α in ameloblastoma. Biochemical and Biophysical Research Communications. 2014;451(4):491-6.
- Kim J-H. Interleukin-8 in the tumor immune niche: lessons from comparative oncology. Tumor Microenvironment: The Role of Interleukins–Part A. 2020:25-33.
- Neagu D, Escuder-de la Torre O, Vázquez-Mahía I, Carral-Roura N, Rubín-Roger G, Penedo-Vázquez Á, et al. Surgical management of ameloblastoma. Review of literature. Journal of clinical and experimental dentistry. 2019;11(1):e70.
- Gasparro R, Giordano F, Campana MD, Aliberti A, Landolfo E, Dolce P, et al. The effect of conservative vs. radical treatment of ameloblastoma on recurrence rate and quality of life: an umbrella review. Journal of Clinical Medicine. 2024;13(17):5339.
- Dandriyal R, Gupta A, Pant S, Baweja HH. Surgical management of ameloblastoma: Conservative or radical approach. National journal of maxillofacial surgery. 2011;2(1):22-7.